- Novo Nordisk signs $812 mln drug license deal with Deep Apple; Novo plans late-stage trials of obesity drug amycretin.
- US FDA approves Nuvation Bio's lung cancer therapy.
- Demant expands in German through 700 million euro Kind deal
- Dynavax elects all four of its nominees after Deep Track proxy fight.
- BioNTech to acquire CureVac in $1.25 billion all-stock deal.
- Cardinal Health raises annual profit target.
- Monash IVF CEO quits days after 2nd embryo mix-up in 2 months.
- Halma hits record high after upbeat revenue forecast.
- US FDA approves UroGen's bladder cancer drug.
|
|
|
States would struggle to administer food stamp benefits under Republican tax bill |
|
|
Air pollution affects fetal brain development |
Brain development in the womb is affected by the mother's level of exposure to air pollution, researchers have found, although it's not clear whether the brain structure differences observed will cause any issues later. Researchers in Barcelona analyzed data collected between 2018 and 2021 from 754 mother-fetus pairs. During the third trimester of pregnancy, participants underwent transvaginal neurosonography, a specialized ultrasound that allows the analysis of fetal brain shape and structures. Higher prenatal exposure to nitrogen dioxide, particulate matter, and black carbon in pregnant women's homes, workplaces, and commuting routes was associated with an increase in the volumes of multiple brain regions that contain cerebrospinal fluid, the researchers reported in The Lancet Planetary Health. Higher exposure to black carbon was also linked with a reduction in the depth of a groove in the brain called the lateral sulcus, which the researchers said might suggest less maturation of the brain. All measurements of brain structures were within the range considered normal, however. "At this stage, we can only report having observed differences in the brains of fetuses with higher exposure to pollution compared to those with lower exposure," senior study author Jordi Sunyer of the Barcelona Institute for Global Health said in a statement. "Additional research is needed to determine whether these effects are reversible after birth or if they persist, and whether they have any implications for neurodevelopmental outcomes in later stages." |
|
|
Top Health News on Reuters.com |
|
|
Scientists discover how common painkiller really works |
Scientists have been wrong about how acetaminophen eases pain, a discovery that could lead to new pain management approaches, researchers reported in PNAS. For decades, scientists believed that acetaminophen, the main ingredient in Tylenol - known in some countries as paracetamol - relieved pain by working only in the brain and spinal cord. But researchers have discovered the drug also works outside the brain, in the nerves that first detect pain. After the drug is ingested, the body processes it into a metabolite called AM404. The new study found in laboratory experiments that AM404 is produced in pain-sensing nerve endings, where it shuts off specific channels that help transmit pain signals to the brain. By blocking these sodium channels, AM404 stops the pain message before it even starts, the researchers said. "This is the first time we've shown that AM404 works directly on the nerves outside the brain," study leader Alexander Binshtok of Hebrew University in Israel said in a statement. "It changes our entire understanding of how paracetamol fights pain." The discovery could lead to new types of painkillers that mimic the effects of AM404, the researchers suggested. Because AM404 targets only the nerves that carry pain, such drugs may avoid some of the side effects of traditional painkillers, they said. |
|
|
Rare appendix cancers spike among Gen X, millennials |
U.S. appendix cancer rates, while still low, have been climbing dramatically in younger adults, according to a report published in Annals of Internal Medicine. Appendix cancer rates were three times higher among people born between 1975 and 1985, and four times higher among those born between 1981 and 1989, than among people born in the 1940s, based on national U.S. population data. The conclusions are drawn from the nearly 4,900 adults who were diagnosed with appendix cancer in the United States between 1975 and 2019. The pattern of increasing cancer rates held true, to varying degrees, for all tumor types, including nonmucinous, mucinous, goblet cell, or signet ring cell carcinoma, the researchers said. Rates of colon cancers and other gastrointestinal malignancies have also been rising in younger adults, for reasons that remain unclear, the researchers noted. "It really struck our curiosity... Would we observe similar patterns in rare appendix cancers?" said study leader Dr. Andreana Holowatyj of Vanderbilt University Medical Center in Nashville, Tennessee. "And certainly the answer was yes," "The big question remains as to why is this happening," she added. "But what's most important is that as these higher risk birth cohorts continue to age, it's likely these rates will continue to increase." In a separate study reported at a recent meeting of cancer doctors, Holowatyj and colleagues found that patients with appendix cancer generally experienced several months of abdominal pain, bloating, and pelvic pain before diagnosis. |
|
| This newsletter was edited by Bill Berkrot; additional reporting by Shawana Alleyne-Morris. |
Reuters Health Rounds is sent twice a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you've engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions |
|
|
|
No comments:
Post a Comment